Valiant Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	2,375	1,334	1,821	3,339	3,124
Other Revenue	23.2	-	-	-	-
Revenue	2,398	1,334	1,821	3,339	3,124
Revenue Growth (YoY)	79.77%	-26.74%	-45.48%	6.90%	-
Cost of Revenue	1,972	1,170	1,705	2,789	2,530
Gross Profit	426.24	163.9	115.76	549.82	594.07
Selling, General & Admin	69.98	43.88	43.13	46.13	33.44
Other Operating Expenses	269.16	166.81	156.71	152.79	101.43
Operating Expenses	399.54	231.62	219.49	214.55	159.13
Operating Income	26.71	-67.72	-103.73	335.28	434.94
Interest Expense	-19.03	-1.74	-0.78	-2.54	-0.36
Interest & Investment Income	-	30.27	26.77	0.97	8.31
Currency Exchange Gain (Loss)	-	-0.15	2.89	5.83	8.72
Other Non Operating Income (Expenses)	0	19.48	58.74	3.45	1.05
EBT Excluding Unusual Items	7.68	-19.86	-16.11	342.99	452.66
Gain (Loss) on Sale of Investments	-	4.73	8.42	38.37	-
Pretax Income	7.68	-15.13	-7.7	381.36	452.66
Income Tax Expense	40.36	6.89	-10.89	91.38	111.93
Net Income	-32.68	-22.01	3.2	289.98	340.74
Net Income to Common	-32.68	-22.01	3.2	289.98	340.74
Net Income Growth	-	-	-98.90%	-14.89%	-
Shares Outstanding (Basic)	64	43	38	33	33
Shares Outstanding (Diluted)	64	43	38	33	33
Shares Change (YoY)	47.47%	14.33%	16.72%	-	-
EPS (Basic)	-0.51	-0.51	0.08	8.91	10.46
EPS (Diluted)	-0.51	-0.51	0.08	8.91	10.46
EPS Growth	-	-	-99.06%	-14.88%	-
Free Cash Flow	-446.32	-1,125	-439.85	183.7	49.48
Free Cash Flow Per Share	-6.96	-25.90	-11.57	5.64	1.52
Gross Margin	17.78%	12.29%	6.36%	16.47%	19.02%
Operating Margin	1.11%	-5.08%	-5.70%	10.04%	13.92%
Profit Margin	-1.36%	-1.65%	0.18%	8.68%	10.91%
Free Cash Flow Margin	-18.61%	-84.37%	-24.16%	5.50%	1.58%
EBITDA	87.1	-48.7	-85.98	349.23	456.55
EBITDA Margin	3.63%	-3.65%	-4.72%	10.46%	14.62%
D&A For EBITDA	60.4	19.02	17.75	13.95	21.61
EBIT	26.71	-67.72	-103.73	335.28	434.94
EBIT Margin	1.11%	-5.08%	-5.70%	10.04%	13.92%
Effective Tax Rate	525.40%	-	-	23.96%	24.73%
Revenue as Reported	2,398	1,388	1,917	3,388	3,149

Source: S&P Global Market Intelligence. Standard template. Financial Sources.